期刊文献+

桑仙降压颗粒对高血压病病人血压和内皮功能的影响 被引量:7

The Effect of Sang Xian Jiang Ya Granule on Hypretention Patients'ABPM and ET Function
下载PDF
导出
摘要 目的 观测桑仙降压颗粒对高血压病人动脉血压的影响 ,并通过对内皮功能的监测探讨降压机制。方法 将高血压病人分层随机分为实验组40例和牛黄降压丸对照组 40例 ,两组均以 2 8d为 1个疗程 ,治疗结束后 ,观测病人血压变化、血浆内皮素(ET)、血清一氧化氮 (NO )含量。结果 桑仙降压颗粒能显著降低 2 4h平均血压 (包括日夜间均值 )、血压负荷、减缓血压的波动性 ,尤其在改善收缩压各参数值方面明显优于牛黄降压丸 ;同时桑仙降压组血浆ET水平下降 ,NO含量上升。结论 桑仙降压颗粒通过影响内皮功能 。 Objective To investigate the effect of Sang Xian Jiang Ya Granule (SXJYG) on hypertension patients' ABPM and discuss its mechanisms by monitoring endothelial function.Methods Eighty middle and elder patients were randomly divided into SXJYG group and Niu Huang Jiang Ya pill(NHJYP) group .The treatment lasted for four weeks.Results Compared to NHJYP, SXJYG could significantly lessen 24 h mean blood pressure(BP) , BP load and BP fluctuation,especially to the parameter about systolic pressure.At the same time, SXJYG could reduce the secretion of endothlin(ET) and increase the secretion of nitric oxide(NO).Conclusion SXJYG had functions of decreasing hypertension through affecting endothelial function , reducing the secretion of endothlin(ET) and increase the secretion of nitric oxide(NO).
作者 张蕴慧
出处 《中西医结合心脑血管病杂志》 2004年第9期497-499,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 山东省科委资助课题 (No.971 2 2 641 0 )
关键词 桑仙降压颗粒 高血压 血压 内皮功能 Sang Xian jiang Ya granule hypertension ABPM endothelial function
  • 引文网络
  • 相关文献

参考文献15

  • 1沈自尹 王文健.中医虚证辨证参考标准[J].中西医结合杂志,1986,6(10):598-598.
  • 2王瑞冬,汪兰珍.老年高血压的动态血压监测[J].中华老年医学杂志,1997,16(3):159-161. 被引量:23
  • 3张玉传,阮萍,马建群,孙经武.动态血压负荷值对高血压病并靶器官损害的评价[J].临床心血管病杂志,1997,13(5):286-287. 被引量:13
  • 4张麟,赵军,李运乾,黄明光.原发性高血压患者的动态血压昼夜节律[J].中国循环杂志,1995,10(8):454-456. 被引量:7
  • 5汤健 唐朝枢 杨军 等.内皮素[M].北京:北京医科大学中国协和医科大学联合出版社,1994.199.
  • 6Steassen. Ambulatory blood presure in clinical trals[J]. J Hypertens, 1991,9(supp1 1) :S13.
  • 7Roden J, Campos C, Narciso M L, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: Aprospective study[J ]. Hypertens, 1998,31: 712.
  • 8Palmer RMT.Nitric oxide release acouts for the biological activity of endothelium-derived relaxing factor[J].1987,327,524-526.
  • 9WHO- ISH Hyertension Guidelines Committee. 1999 World Health Organization: intenational society of hyertension guidelines for the management of hypertension [ J ]. J Hypertens, 1999,17: S12 - S13.
  • 10White WB. Twenty- four- hour blood pressure loadas a surrogate end - poit in assessing antihypertensive therapy [ J ].Hypertens, 1993,11 (Supp1 4) :75 - 80.

二级参考文献5

共引文献633

同被引文献71

引证文献7

二级引证文献12

相关主题

;
使用帮助 返回顶部